Kennedy Capital Management LLC decreased its stake in Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) by 19.2% in the first quarter, HoldingsChannel reports. The firm owned 177,900 shares of the construction company’s stock after selling 42,368 shares during the period. Kennedy Capital Management LLC’s holdings in Aspen Aerogels were worth $3,131,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the stock. GSA Capital Partners LLP acquired a new position in shares of Aspen Aerogels in the first quarter worth about $1,181,000. Federated Hermes Inc. raised its stake in Aspen Aerogels by 53.9% during the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after purchasing an additional 404,042 shares during the period. Oppenheimer & Co. Inc. purchased a new stake in shares of Aspen Aerogels in the first quarter valued at $388,000. AIGH Capital Management LLC boosted its position in shares of Aspen Aerogels by 3.0% in the fourth quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock worth $28,475,000 after buying an additional 52,462 shares during the period. Finally, Mesirow Institutional Investment Management Inc. acquired a new stake in shares of Aspen Aerogels in the fourth quarter worth $12,015,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Aspen Aerogels Stock Performance
Shares of Aspen Aerogels stock traded up $0.77 on Wednesday, hitting $21.03. The company had a trading volume of 163,330 shares, compared to its average volume of 1,152,874. Aspen Aerogels, Inc. has a twelve month low of $5.32 and a twelve month high of $31.74. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24. The stock has a 50-day moving average of $26.50 and a 200-day moving average of $20.29.
Analyst Ratings Changes
Several brokerages recently issued reports on ASPN. TD Cowen increased their price objective on Aspen Aerogels from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Wednesday, June 5th. Canaccord Genuity Group boosted their target price on Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. Roth Mkm reiterated a “buy” rating and issued a $36.00 price objective (up previously from $28.00) on shares of Aspen Aerogels in a research report on Wednesday, June 12th. Piper Sandler raised their target price on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, May 29th. Finally, Craig Hallum raised their price target on Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a report on Friday, June 14th. One research analyst has rated the stock with a sell rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.75.
Insider Activity
In other Aspen Aerogels news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $23.50, for a total transaction of $82,250,000.00. Following the sale, the insider now directly owns 12,280,426 shares of the company’s stock, valued at approximately $288,590,011. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Aspen Aerogels news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $23.50, for a total transaction of $82,250,000.00. Following the transaction, the insider now owns 12,280,426 shares of the company’s stock, valued at approximately $288,590,011. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Keith L. Schilling sold 20,000 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $26.84, for a total value of $536,800.00. Following the completion of the sale, the senior vice president now directly owns 28,792 shares of the company’s stock, valued at approximately $772,777.28. The disclosure for this sale can be found here. Insiders have sold 3,832,103 shares of company stock worth $91,679,369 over the last ninety days. Insiders own 4.30% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- Basic Materials Stocks Investing
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- What is a buyback in stocks? A comprehensive guide for investors
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- What is Forex and How Does it Work?
- 5 Aggressive Growth Stocks for Long-Term Investors
Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN – Free Report).
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.